about
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givasto...
Read More
1.60
-0.01
(-0.62%)
238.2K
XNAS Volume
XNAS 24 Jun, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
I-Mab (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..